Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Melphalan × Clear all

Sponsor

Conditions

Multiple Myeloma 92 Lymphoma 41 Hodgkin Disease 37 Myelodysplastic Syndromes 36 Lymphoma, Non-Hodgkin 36 Leukemia, Myeloid, Acute 34 Leukemia 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia, Lymphocytic, Chronic, B-Cell 23 Neoplasms, Plasma Cell 20 Lymphoma, Mantle-Cell 19 Lymphoma, Follicular 19 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, B-Cell, Marginal Zone 14 Burkitt Lymphoma 14 Myeloproliferative Disorders 12 Leukemia, Myeloid, Accelerated Phase 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Immunoglobulin Light-chain Amyloidosis 12 Recurrence 11 Primary Myelofibrosis 11 Hematologic Neoplasms 11 Congenital Abnormalities 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myelomonocytic, Juvenile 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Chronic-Phase 10 Lymphoma, T-Cell, Cutaneous 9 Dendritic Cell Sarcoma, Interdigitating 8 Blast Crisis 8

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡